1. Home
  2. ENVB vs DGLY Comparison

ENVB vs DGLY Comparison

Compare ENVB & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • DGLY
  • Stock Information
  • Founded
  • ENVB 1994
  • DGLY 2004
  • Country
  • ENVB United States
  • DGLY United States
  • Employees
  • ENVB N/A
  • DGLY N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • ENVB Health Care
  • DGLY Technology
  • Exchange
  • ENVB Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • ENVB 3.0M
  • DGLY 2.8M
  • IPO Year
  • ENVB N/A
  • DGLY N/A
  • Fundamental
  • Price
  • ENVB $5.63
  • DGLY $1.23
  • Analyst Decision
  • ENVB Strong Buy
  • DGLY
  • Analyst Count
  • ENVB 1
  • DGLY 0
  • Target Price
  • ENVB $120.00
  • DGLY N/A
  • AVG Volume (30 Days)
  • ENVB 128.8K
  • DGLY 37.4K
  • Earning Date
  • ENVB 11-14-2025
  • DGLY 12-29-2025
  • Dividend Yield
  • ENVB N/A
  • DGLY N/A
  • EPS Growth
  • ENVB N/A
  • DGLY N/A
  • EPS
  • ENVB N/A
  • DGLY N/A
  • Revenue
  • ENVB N/A
  • DGLY $19,097,965.00
  • Revenue This Year
  • ENVB N/A
  • DGLY N/A
  • Revenue Next Year
  • ENVB N/A
  • DGLY $7.38
  • P/E Ratio
  • ENVB N/A
  • DGLY N/A
  • Revenue Growth
  • ENVB N/A
  • DGLY N/A
  • 52 Week Low
  • ENVB $4.88
  • DGLY $1.20
  • 52 Week High
  • ENVB $96.30
  • DGLY $1,960.00
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 59.55
  • DGLY 16.70
  • Support Level
  • ENVB $4.88
  • DGLY $1.58
  • Resistance Level
  • ENVB $6.10
  • DGLY $1.74
  • Average True Range (ATR)
  • ENVB 0.90
  • DGLY 0.08
  • MACD
  • ENVB -0.19
  • DGLY -0.04
  • Stochastic Oscillator
  • ENVB 20.64
  • DGLY 13.10

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: